THE Ministry of Equity, Social Justice and Empowerment via its division of Human Services and Family Affairs, has expressed profound gratitude to the Japan Relief Clothing Center for their recent donation of over 100 cartons of essential clothing items.
UCB announces approval of RYSTIGGO® (rozanolixizumab) and ZILBRYSQ® (zilucoplan) for the treatment of adult patients with generalized myasthenia gravis in JapanJapanese Ministry of Health, Labour and Welfare (MHLW) approves two UCB treatments, RYSTIGGO® (rozanolixizumab) and ZILBRYSQ® (zilucoplan), f.
UCB announces approval of RYSTIGGO[®] and ZILBRYSQ[®] for the treatment of adult patients with generalized myasthenia gravis in Japan Japanese Ministry.